Abstract
A simple, rapid, precise, and accurate high-performance thin-layer chromatographic method coupled with visible densitometric detection of artemisinin is developed and validated. Samples of the dried Artemisia annua leaves were extracted via microwaves using different solvents. This method shows the advantage of shorter extraction time of artemisinin from leaves under the influence of electromagnetic radiations. Results obtained from microwave-assisted extraction (MAE) were compared with hot soxhlet extraction. Chromatographic separation of artemisinin from plant extract was performed over silica gel 60 F254 HPTLC plate using n-hexane : ethyl acetate as mobile phase in the ratio of 75 : 25, v/v. The plate was developed at room temperature 25 ± 2.0°C. Artemisinin separation over thin-layer plate was visualized after postchromatographic derivatization with anisaldehyde-sulphuric acid reagent. HPTLC plate was scanned in a CAMAG’s TLC scanner 3 at 540 nm. Artemisinin responses were found to be linear over a range of 400–2800 ng spot−1 with a correlation coefficient 0.99754. Limits of detection and quantification were 40 and 80 ng spot−1, respectively. The HPTLC method was validated in terms of system suitability, precision, accuracy, sensitivity (LOD and LOQ), and robustness. Additionally, calculation of plate efficiency and flow constant were included as components of validation. Extracts prepared from different parts of the plant (leaves, branches, main stem, and roots) were analyzed for artemisinin content, in which, artemisinin content was found higher in the leaf extract with respect to branches and main stem extracts; however, no artemisinin was detected in root extract. The developed HPTLC-visible method of artemisinin determination will be very useful for pharmaceutical industries, which are involved in monitoring of artemisinin content during different growth stages (in vitro and in vivo) of A. annua for qualitative and quantitative assessment of final produce prior to commercial-scale processing for assessment of cost-benefit ratio.
Highlights
Malaria is a vector-borne infectious disease, which affects approximately 400 million people every year, especially in Africa
Mannan et al (2010) collected 17 different Artemisia species from different hilly locations in northern Pakistan and screened for the presence of artemisinin; results of this study revealed that artemisinin was present in 16 species
Soxhlet extraction showed good recovery of artemisinin with n-hexane in comparison to chloroform, methylene dichloride, ethyl acetate, and acetone; we, have selected soxhlet extraction with n-hexane as control for this study and further optimization results will be compared with control value of artemisinin content, that is, 0.772%, while other high boiling solvents could not yield that much artemisinin content due to lesser numbers of leaching which occurred during 6 h
Summary
Malaria is a vector-borne infectious disease, which affects approximately 400 million people every year, especially in Africa. The first effective antimalarial drug to treat this dangerous infection was quinine; since malaria has been treated with quinoline-based drugs like chloroquine, mefloquine, and pyrimethamine, but malaria parasite developed resistance to these drugs [1,2,3]. Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, introduced Artemisia annua in India and developed its agrotechnology for commercialized production of active antimalarial drug, artemisinin [4,5,6,7,8]. Artemisinin has received much attention in the treatment of drug-resistant malaria in recent years, and it is considered a potential candidate to reduce coccidial infection in chickens [9, 10]. Artemisinin and its derivatives possess several bioactivities [11] including antiviral [12], antitumor [13], and anticancer [14]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
